Medtronic CEO Omar Ishrak seeks to reassure employees amid the political fallout over the tax inversion aspects of its $43 billion deal to acquire Covidien.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1m2RxVI
Cap comentari:
Publica un comentari a l'entrada